| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/07/1994 | US5318964 Hydroxamic derivatives and pharmaceutical compositions |
| 06/07/1994 | US5318958 Administering complex of high density lipoprotein and ligand having serum amyloid affinity for high density lipoproteins and promoting macrophage release of cholesterol for elimination |
| 06/07/1994 | US5318524 Fibrin sealant delivery kit |
| 06/05/1994 | CA2110553A1 Organic compounds |
| 06/04/1994 | CA2110520A1 1,4-benzoxazine derivatives |
| 06/01/1994 | EP0599697A1 Pyrrole derivatives, their preparation and application in therapy |
| 06/01/1994 | EP0599514A2 Pyranoquinoline derivatives as inhibitors of cell proliferation |
| 06/01/1994 | EP0599444A1 Dual action inhibitors |
| 06/01/1994 | EP0599220A1 A process for the preparation of amlodipine benzenesulphonate |
| 06/01/1994 | EP0599152A1 Triazinones and Triazinophthalazinones possessing antiasthmatic/antiallergic, positive inotropic and antihypertensive activities |
| 06/01/1994 | EP0598770A1 New pyrazine derivatives, their preparation and their use. |
| 06/01/1994 | EP0598753A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 06/01/1994 | EP0484437A4 Renal-selective prodrugs for the treatment of hypertension |
| 06/01/1994 | CN1087278A New use of lysozyme dimer and compositions containing the same |
| 06/01/1994 | CN1087275A Shumaining preparation for curing ischemic angiocardiopathy or cerebrovascular disease |
| 06/01/1994 | CN1024793C Method for preparation of pyrimiding derivatives |
| 06/01/1994 | CN1024791C Process for preparing pyrrolidine derivatives and their salts |
| 06/01/1994 | CN1024790C Urea derivatives and salts thereof and method for producing same |
| 05/31/1994 | US5317023 2-Phenyl-(imidazo(4,5-b)pyridyl-methyl-) derivatives; hypertensive agents; cognition activators |
| 05/31/1994 | US5317020 Aromatic amine compounds their method of preparation and pharmaceutical compositions in which they are present |
| 05/31/1994 | US5316919 Genetic engineering; vasodialtors, hypotensive and bronchodilator agents |
| 05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011370A1 Substituted amino alkyl compounds |
| 05/26/1994 | WO1994011368A1 Quinuclidine derivative as substance p antagonist |
| 05/26/1994 | WO1994011342A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 05/26/1994 | WO1994011007A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | WO1994010990A1 Inhibition of tnf production |
| 05/26/1994 | DE4239150A1 O-acyl-4-phenyl-cyclohexanol derivs. - are inhibitors of 2,3-epoxy:squalene-lanosterol cyclase and useful as anti-hypercholesterolaemic for treating atherosclerosis |
| 05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | CA2149046A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | CA2136077A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis |
| 05/26/1994 | CA2109900A1 Heterocyclic compounds with antiasthmatic/anti-allergic, anti-inflammatory, positive inotropic and blood pressure-reducing effect |
| 05/25/1994 | EP0598702A1 Biphenylmethane derivative, the use of it and pharmacological compositions containing same |
| 05/25/1994 | EP0598093A1 Quinuclidine derivatives as squalene synthetase inhibitors |
| 05/25/1994 | EP0598061A1 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 05/25/1994 | EP0598046A1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 05/25/1994 | EP0598037A1 Buffered formulation of peg-sod |
| 05/25/1994 | EP0597831A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 05/25/1994 | CN1087084A New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloa lkylacetamides |
| 05/25/1994 | CN1087083A Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives |
| 05/25/1994 | CN1087080A Benzenealkanoic acids for cardiovascular diseases |
| 05/25/1994 | CN1086997A A method of vasodilator therapy |
| 05/25/1994 | CN1024667C Process for preparing substituted aminomethytetralins and their heterocyclic analogues |
| 05/25/1994 | CN1024663C Process for preparing substituted tetralins and related compounds in treatment of asthma |
| 05/25/1994 | CA2109774A1 Pyrrole derivatives, preparation and therapeutical use thereof |
| 05/24/1994 | US5315017 Peroxidation and eicosanoid biosynthesis inhibition |
| 05/24/1994 | US5315012 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds |
| 05/24/1994 | US5314907 3-aminochroan compounds |
| 05/24/1994 | US5314903 Benzimidazole compounds useful as calcium channel blockers |
| 05/24/1994 | US5314896 Dopaminergic agents, antipsychotic and hypotensive agents |
| 05/24/1994 | US5314895 Benzopyran class III antiarrhythmic agents |
| 05/24/1994 | US5314880 Benzimidazole derivatives |
| 05/24/1994 | CA1329862C Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
| 05/24/1994 | CA1329807C Cardiotonic tricyclic imidazolones |
| 05/19/1994 | CA2103203A1 Pharmaceutical compounds |
| 05/18/1994 | EP0597540A1 Aryl-fused and hetaryl-fused-2,4-diazocine antiarrhythmic agents |
| 05/18/1994 | EP0597107A1 Lignan analog, production thereof, and hypolipidemic drug |
| 05/18/1994 | EP0596933A1 5-ht4 receptor antagonists |
| 05/18/1994 | EP0596891A1 Aminoalkyl-substituted 2-amino-5-mercaptothiadiazoles, their preparation and their use |
| 05/18/1994 | EP0248819B1 Recombinant fibroblast growth factors |
| 05/18/1994 | CN1086825A The present invention is concerned with tri- and tetracyclic compounds |
| 05/18/1994 | CN1086824A Calcium channel blocking polypeptide from agelenopsis aperta |
| 05/18/1994 | CN1086818A Asymmetrically substituted xanthines |
| 05/18/1994 | CN1086811A Novel nicotincacid esters |
| 05/18/1994 | CN1024551C Process for indole derivatives |
| 05/18/1994 | CN1024550C Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl) methoxy-4R-chromanol |
| 05/18/1994 | CA2109186A1 Aminocarbonyl (thiocarbonyl) and cyanoguanidine derivatives of quinoline and indoline |
| 05/17/1994 | US5312936 Angiotensin II antagonists |
| 05/17/1994 | US5312839 Aminoalkylsulfonic acids for cells |
| 05/17/1994 | US5312835 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
| 05/17/1994 | US5312832 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives |
| 05/17/1994 | US5312816 Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds |
| 05/17/1994 | US5312809 Physiologically active substance derived from malt and process for the production thereof |
| 05/17/1994 | CA1329680C N-heterocyclic alcohol derivatives |
| 05/17/1994 | CA1329618C Aminoalkyl-substituted heterocyclic sulfur compounds |
| 05/17/1994 | CA1329617C Resolved amino pyrrolidine neuroprotective agents |
| 05/17/1994 | CA1329603C 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present |
| 05/17/1994 | CA1329601C Cardiotonic tricyclic oxazolones |
| 05/17/1994 | CA1329600C 1,4-dihydropyridines |
| 05/17/1994 | CA1329594C 5-(substituted)amino)-8-(phenyl or substituted phenyl)-3h,6h-1,4,5a,8a-tetraazaacenaphthyen-3-ones |
| 05/17/1994 | CA1329591C Pharmaceutical products and new lactosyl compounds and the preparation thereof |
| 05/17/1994 | CA1329547C Skin permeation enhancer compositions using glycerol monooleate |
| 05/11/1994 | WO1994010324A1 Ws79089 substances from streptosporangium |
| 05/11/1994 | WO1994010309A1 Novel p-selectin ligand protein |
| 05/11/1994 | WO1994010196A1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/11/1994 | WO1994010195A1 Calcium channel blocking polypeptides from heteropoda venatoria |
| 05/11/1994 | WO1994010193A1 Novel mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace |
| 05/11/1994 | WO1994010187A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b) |
| 05/11/1994 | WO1994010171A1 5-arylindole derivatives and their use as serotonin (5-ht1) agonists |
| 05/11/1994 | WO1994010165A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
| 05/11/1994 | WO1994010157A1 Styrene derivative and salts thereof |
| 05/11/1994 | WO1994010150A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8aβ)-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF |
| 05/11/1994 | WO1994010148A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
| 05/11/1994 | WO1994010142A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 05/11/1994 | WO1994010139A1 Novel vitamin d analogues |
| 05/11/1994 | WO1994009789A1 USE OF 17α-DIHYDROEQUILENIN FOR LOWERING CHOLESTEROL |
| 05/11/1994 | WO1994009786A1 Methods and compositions of (+) doxazosin for the treatment of hypertension |
| 05/11/1994 | WO1994009785A2 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 05/11/1994 | WO1994009772A1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |